TR EN AR RU KK

7805

Teknoloji
🇹🇼 Tayvan Borsası
449.50
TWD
Analysis Scores
Lothien Robustness Score?
72/100
Very Strong
Neden bu skor?
Damodaran ?
44/100
Dalio Risk ?
99/100
Piotroski ?
4/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
NT$415.8
Pahalı
Active Metric?
4/4
Confidence?
72%
Lothien Robustness Summary
78/100
Lothien Sağlamlık: Çok Güçlü (78/100)
Temel göstergelerin büyük çoğunluğu pozitif. Kârlılık, büyüme ve değerleme açısından güçlü görünüm. | Kısa Vade: Olumlu | Uzun Vade: Olumlu | Pozitif: 6 | Negatif: 2 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte NT$340M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Düşüşü
Net kâr bir önceki çeyreğe göre %-20.8 geriledi (NT$429M → NT$340M). Kısa vadede olumsuz sinyal.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+72.5 arttı. Büyüme trendi sağlıklı.
3 Çeyrek Üst Üste Artış
Son 3 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.
Yüksek Net Kâr Marjı
Net kâr marjı %20.2. Her 100NT$ satıştan 20NT$ kâr kalıyor.
Net Nakit Pozisyonu
Şirketin nakdi borçlarından NT$1.2B fazla. Borç riski düşük.
Kârlı ama Nakit Üretemiyor
Net kâr pozitif (NT$340M) ama FCF negatif (-NT$4M). Yatırım harcamaları yüksek veya alacak birikimi var.
Makul F/K
Trailing F/K: 11.5. Makul değerleme aralığında.
Lothien Sağlamlık Skoru: 72/100
Bileşik algoritma değerlendirmesine göre şirketin finansal yapısı güçlü görünüyor.
Mevsimsel Etki
Çeyreklik düşüş (%-20.8) ama yıllık bazda artış (%+72.5). Bu muhtemelen mevsimsel bir düşüş.

Data date 2026-10-22 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Method How the scores are computed · Scorecard
Data date 2026-10-22
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Yüksek
252 days
Annual Volatility ?
%46.8
VaR 95% ?
%5.01
daily max loss
VaR 99% ?
%7.02
daily max loss
CVaR 95% ?
%6.51
expected loss (tail)
Max Drawdown ?
%44.4
02.12.2025 → 22.10.2026
Skewness ?
0.08
Parametrik%5.01
Historik%4.16
Cornish-Fisher%4.57
Return Distribution
Valuation
Potential?
+25.2%
ROIC ?
19.7%
DCF Value ?
90.47
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/6
Net kâr çeyreklik %-20.8 düşerek 339.8M TWD oldu
Yıllık net kâr büyümesi %+72.5
Hasılat çeyreklik %-5.0 düştü (1.7B TWD)
Yıllık hasılat büyümesi güçlü (%+13.6)
Brüt kâr marjı güçlü: %58.5
Brüt marj değişimi: %-2.8 puan
Net kâr marjı yüksek: %20.2
FAVÖK çeyreklik %-19.5 düştü (490.5M TWD)
FAVÖK marjı güçlü: %29.2
Toplam borç: 343.7M TWD
Net nakit pozisyonunda: -1.2B TWD (borçsuz)
Borç/Özkaynak oranı düşük: 0.04x
Cari oran: 1.90x — yeterli likidite
Nakit ve benzerleri: 1.6B TWD
İşletme nakit akışı pozitif: 53.6M TWD
Serbest nakit akışı negatif: -4.4M TWD — yatırımlar nakdi aşıyor
ROE düşük: %4.4
ROA: %3.0
Toplam varlıklar %+7.1 büyüdü → 11.3B TWD
Özkaynak %+9.7 arttı → 7.7B TWD
İşletme kârı pozitif: 437.0M TWD
Faiz karşılama oranı güçlü: 150.7x (Faiz: 3.3M TWD)
Ödenmiş sermaye: 39.8M TWD
Net işletme sermayesi pozitif: 3.0B TWD
CAPEX: 58.0M TWD (Hasılatın %3.5'i)
Son 6 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-25.3 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 601.44 TWD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %20.2
Net profit margin %20.2 — very strong. Compared to previous quarter -4.1 point decrease.
ROE - Return on Equity (TTM) %21.3
ROE %21.3 — high return on equity.
EBITDA Margin %29.2
EBITDA margin %29.2 — operationally very efficient.
Gross Profit Margin %58.5
Gross profit per revenue %58.5. Strong pricing power.
Free Cash Flow Margin (TTM) %3.1
TTM Free Cash Flow is %3.1'i. Moderate FCF — capex constraining operational profit.
Valuation
P/E Ratio 11.5x Sector: 27.4x
F/K 11.5x — sector median's (27.4x) %58 below. Attractive for value investing.
P/B Ratio 2.35x Sector: 3.45x
PD/DD 2.35x — sector median's (3.45x) well below. Cheap relative to book value.
EV/EBITDA 8.2x Sector: 14.9x
EV/EBITDA 8.2x — sector median's (14.9x) %45 below. Cheap relative to EBITDA.
Indebtedness
Current Ratio 1.90x
Current ratio 1.90x — can comfortably cover short-term debts.
Net Debt / EBITDA 0.2x
Net Debt/EBITDA 0.2x — very low debt burden. Company can repay debt quickly.
Debt / Equity 0.04x
Low leverage — majority of assets financed by equity.
Interest Coverage 393.3x
Interest coverage 393.3x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+13.6
Revenue YoY %13.6 grew — healthy growth rate.
Net Profit Growth (YoY) %+72.5
Net profit YoY %72.5 increased (2026/6) — extraordinary profit growth.
Score Explanations
Lothien Robustness
72/100
Very strong robustness score (72/100). Damodaran valuation, Dalio risk analysis and balance sheet quality criteria are largely met.
Very Strong
Potential
+25.2%
Plus %25.2 expected value (570.97) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %72.
Components: PE target: 1076.48 | P/B target: 702.76 | EV/EBITDA target: 829.17 | DCF target: 114.00
Damodaran Valuation
44/100
Low Damodaran score (44/100). DCF analysis does not support current price.
Weak
Dalio Risk Analysis
99/100
Low debt risk (99/100). Interest coverage ratio 393.3x — strong. Debt/EBITDA 0.2x — in healthy range.
Leverage: 97/100 | Debt Service: 98/100 | Quality: 100/100
ROIC - Return on Capital
%19.7
ROIC (%19.7) cost of capital 6.7 bps above → company creates value.
WACC: %13.0
DCF Discounted Cash Flow
90.47
DCF (90.47) current price %80.2 below — cash flows do not support current price.
Current price: 456.00
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
NT$415.8
Expensive
⚖️ Sector Comparison
P/E Ratio
11.5x vs 27.4x
Sector median's %58 below — cheap
P/B Ratio
2.35x vs 3.45x
Compared to sector %32 cheaper (by book value)
EV/EBITDA
8.2x vs 14.9x
Compared to sector %45 lower EV/EBITDA
ROIC vs WACC
%19.7 vs %13.0 WACC
ROIC 6.7 bps above cost of capital
Net Profit Margin (TTM)
%23.8 vs %31.2 EBITDA margin
TTM net profit margin %23.8
TRAMA-99 Trend — Strong Downtrend
Price (449.50), TRAMA-99 line's %25.3 below. Significant downtrend. TRAMA line acts as strong technical resistance.
Price:: 449.50
TRAMA: 601.44
Difference: %-25.3
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
7805 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.